Skandinaviska Enskilda Banken (SEB)
FBIO icon

Skandinaviska Enskilda Banken (SEB)’s Fortress Biotech FBIO Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-190
Closed -$12K – 1140
2020
Q3 		$12K Hold
190
– – ﹤0.01% 999
2020
Q2 		$8K Buy
+190
New +$7.06K ﹤0.01% 1044

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s FBIO Position: Q4 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Fortress Biotech (FBIO) in Q4 2020, closing a stake of 190 shares — an estimated $12K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in FBIO in Q2 2020 and held it in 2 quarters. The position peaked at $12K in Q3 2020. 87 funds tracked by Wall St. Rank hold FBIO as of Q4 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Fortress Biotech position as of Q4 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 190 Fortress Biotech shares in Q4 2020, an estimated $12K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Fortress Biotech in Q2 2020 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Fortress Biotech position peaked at $12K in Q3 2020.
  • 87 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2020, filed 11 Feb 2021.